This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Curavac Inc., The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016-2019
Title: Edwin J Blalock: Innovator in Medical Therapeutics
Introduction
Edwin J Blalock is a notable inventor based in Vestavia Hills, AL (US). He has made significant contributions to the field of medical therapeutics, particularly in the treatment of conditions such as fibrosis and myasthenia gravis. With a total of 2 patents, his work reflects a commitment to advancing healthcare solutions.
Latest Patents
Blalock's latest patents include innovative compositions and methods for inhibiting fibrosis. These compositions are designed to treat or prevent fibrosis, showcasing his dedication to addressing complex medical issues. Additionally, he has developed a vaccine aimed at the therapeutic or prophylactic treatment of myasthenia gravis. This therapeutic composition comprises a complementary peptide that targets a major immunogenic region of the acetylcholine receptor involved in myasthenia gravis, along with other essential components.
Career Highlights
Throughout his career, Edwin J Blalock has worked with reputable organizations, including the UAB Research Foundation and Curavac Inc. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Blalock has collaborated with esteemed colleagues such as Philip J O'Reilly and Stephane P Huberty. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Edwin J Blalock's contributions to medical therapeutics through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for new treatments that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile